29 janvier 2009
New method of treating
Multiple Sclerosis - Prof. K. Jung, University of Mainz
Case study
Female teacher, born 1963.
First episode of multiple sclerosis (MS) in autumn 2003, medical
diagnosis in spring 2004, Prednisone treatment, 7 week course.
Since then Rebif® 44 injected 3 times per week, numerous
side effects. Consequently considered possibilities of naturopathic
treatment, initially magnetic field therapy, symptoms began to
improve. After switching to energised inhaled air immediate improvement
in mobility, patient increasingly felt better, long-term state
of health significantly improved with no onset (felt ready to
tackle anything). To provide more detail, various symptoms since
autumn 2003 which were attributed to MS in 2004 and whose frequency
and intensity reduced considerably since beginning Airnergy therapy
(sensitivity on lowering the head, tingling in fingertips, no
reaction to pinching and pricking in upper abdomen, legs tired
easily when climbing stairs, blurred vision, disorders of the
bladder/intestines, problems concentrating, permanently tired,
mood fluctuations).
From the patients
subjective viewpoint, while inhaling energised air she felt so
tired she could fall asleep; afterwards she felt increasingly
fit, resilient, capable and focused. Objectively she continued
to find climbing stairs just as difficult, however her symptoms
reduced markedly.
Following years of therapy
with energised inhaled air she concluded that her condition was
not cured but that, from a subjective viewpoint, her symptoms
had been alleviated significantly on an on-going basis so that
she was able to pursue her career.
A follow-up examination
in November 2005 did indeed reveal minor non-specific biparietal
occipital changes to the white matter although these had regressed
since 2003 and no pathological disorder of the blood-brain barrier.
The findings had not deteriorated in 2007 either in that slack
vaguely defined signal increases could still be identified biparietal-occipitally.
These were characterised as non-specific and not morphologically
typical of MS and there was no indication of rapid advance of
the process.
Definition
Multiple sclerosis (MS),
also known as encephalomyelitis disseminata, chronic disseminated
encephalomyelitis, demyelinating encephalomyelitis, polysclerosis,
sclerosis multiplex and Charcots disease.
Primarily independent and
organotypic inflammatory disease of the white matter of the brain
and of the spinal cord with disseminated multilocular topography
and varying dynamics due to exogenously (virally) induced and
endogenous auto-antigen neuroimmunological processes resulting
in selective demyelination. Perivascular and periventricular
lympho-plasmacytic infiltrates are apparent morphologically.
As the disease progresses, membranolytic processes occur due
to the action of lysosomal enzymes with localised discontinuous
demyelination and subsequent glia cell proliferation.
This leads to multiple
and varying neurological symptoms where remissions and exacerbations
are both possible and common.
Statistics
Most common neurological
disease among young fair-skinned people, especially between the
ages of 20 and 40, rare in the under 10s and over 50s. Women
are affected more often than men; the ratio is between around
1.2 and 2.0 to 1. Family clusters can be seen in up to 12 percent
of cases. Incidence decreases from north to south, in Germany
around 50, in Japan/Africa/ South America some 4 cases per 100,000
inhabitants. Likely association with certain HLA allotypes. Symptoms
aggravated by poor lifestyle, especially through stress.
Aetiology and pathogenesis
The aetiopathogenesis has
not been conclusively explained. In recent years the view has
generally been taken that a combination of different factors
is present.
Genetic immunological factors
seem to play a definite part especially human leukocyte antigens
(HLA system), a complex codominant hereditary antigen system
in humans whose components take effect as histocompatibility
antigens of differing strength. Increased occurrence of individual
HLA antigens has been detected with certain diseases, such as
Bechterews disease, adrenogenital syndrome and MS.
Moreover exogenous induction
through viruses is under discussion indicated by the persistence
of abnormal paramyxoviruses and lymphotropic retroviruses where
viral activation and its expression trigger a secondary immune
response.
Ultimately an endogenous
autoimmunological process has also been considered since there
is evidence of antigen release and typical cellular immune response
and antibody abnormality. According to the currently most widely
held view, genetic determination together with acquired cell
membrane abnormalities could upset immune regulation especially
in the face of a so-called slow virus infection with subsequent
auto immune response which could take effect as impaired immune
tolerance and by sensitising against the bodys own basic
myelin protein. Defects in suppressor T cell activity and mediators
and antibodies penetrating the blood-brain barrier would be the
inevitable consequence and the actual cause of the subsequent
symptoms.
The anatomical manifestation
of MS relates to disseminated perivascular inflammatory foci
and demyelinated patches with destruction of the oligodendroglia,
an important component of the neuroglia of the central nervous
system which, in the central grey matter, has direct contact
with the nerve cells and, in the white matter, forms myelin and
builds up the myelin sheath.
MS tends to affect the
lateral and posterior white column of the spinal cord, the optic
nerve and periventricular areas, also tracts of the midbrain
and parts of the pons and cerebellum.
The cell bodies themselves
and also the axons are still intact, at least at the start. Later
the axons are affected by the pathological process, a fibrous
gliosis giving them a sclerotic appearance, resulting in dysfunction
of the central nervous system.
Clinical features
Clinically MS is characterised
by multilocular changing symptoms which vary widely and whose
severity depends on the number and location of the foci. Typical
forms are, on the one hand, the episodic remittent and, on the
other, the chronic protracted form. These are all indications
that the central nervous system is starting to be affected and
it may be months or even years before the condition is finally
diagnosed. The syndrome generally progresses and ends with spastic
para- or tetraplegia with the primarily chronic protracted and,
especially the malignant form, delivering the far less favourable
prognosis. Life expectancy is not generally affected except in
extremely severe cases.
Certain symptoms generally
dominate:
Retrobulbar neuritis
Occurs in around 40 percent
of all MS cases. Those affected complain of increased sensitivity
to light, painful eye movements and impaired vision or even sudden
blindness in one eye which, in the initial stages of MS, generally
disappears of its own accord within 2 to 3 weeks. As a consequence
of increasing demyelination, papilloedema with accompanying impaired
vision may develop in the later stages. Central or paracentral
scotoma can also appear as well as double vision as part of transient
ophthalmoplegia. As the condition progresses optic atrophy is
also possible with temporal pallor.
Brain stem affection
Possible even in the early
stages. Subjective reports of double vision, dizziness and nystagmus
in 20 to 40 percent of all cases. Trigeminal neuralgia and peripheral
facial weakness are also possible.
Internuclear ophthalmoplegia
Classic sign of multiple
sclerosis. Paralysed adduction of one or both eyes when looking
sidewards is noticed with accompanying nystagmus of the abducing
eye. When then looking left, for example, the right eye is left
behind.
Involvement of the posterior
white column
Complete loss of sensitivity
is certainly rare, paraesthesia and dysaesthesia can however
often be identified in the early stages of MS. When bending the
head, an electric shock feeling or a shooting pain can suddenly
be felt right along the back and arms (lHermittes
sign). Sense of vibration and of position is impaired. Standing
posture with the eyes closed is very unsteady (Rombergs
sign). Pyramidal tract lesion: this is the reason for rapid tiredness,
muscular stiffness, weakness and increased muscle tone in conjunction
with generally simultaneous increased proprioceptive muscle reflex
(e.g. PSR). Brief jerky twitching of individual muscles appears
with no or minimal actual movement. When the soles of the feet
are stimulated, the big toe moves pathologically upwards towards
the knee (Babinskis reflex).
Cerebellar symptoms
Cerebellar symptoms are
present in about 50 percent of all MS cases although rarely in
the early stages. Impaired balance, intension tremor generally
increasing with target movements (often in conjunction with nystagmus
and syllabising: Charcots triad), dysarthria and staggering
with a tendency to fall are typical indications. Movements become
staggering, irregular, tremulous and ineffectual. The gait becomes
stiff and unbalanced. Impairment is generally progressive and
usually leads to severe disability through a combination of spasticity
and cerebral ataxia.
Mental symptoms
These occur in many MS
patients and are usually characteristic of the later stages.
Apathy, loss of critical ability and lack of attention may occur.
Emotional instability such as sudden crying and forced laughter
is observed relatively frequently. Convulsions, mania and dementia
occur in rare cases. Syllabising is typical of later stages.
Indications of the involvement
of the autonomous nervous system
If the spinal column is
involved, an urge to urinate, difficulties in passing urine,
urinary retention and even incontinence as well as constipation
can be expected, in addition to impaired erection in men and
genital synaesthesia in women.
Particularly with the episodic
remittent form of MS but also at the onset of the chronic protracted
form, heat, overtiredness, tension and infections sometimes trigger
double vision, synaesthesia and impaired vision, which cannot
be regarded as true episodes yet tend to take place through delayed
nerve conduction in previously damaged partially demyelinated
nerve tracts. These symptoms are apparently highly responsive
to treatment.
General treatment
It is true in principle
that multiple sclerosis cannot be cured. There is currently no
effective or causal treatment. The course is usually inconsistent,
unpredictable, yet in most cases remittent. Life expectancy is
not generally affected. Initially there may be months and up
to 10 years between individual episodes. With time, however,
the clear intervals become shorter until a state of progressive
permanent invalidity is reached. It is difficult to assess how
successful treatment has been due to the possibility of spontaneous
remission and fluctuating symptoms. Glucocorticoids are often
used to cut short an acute episode and this does indeed reduce
the inflammation, swelling and any pain from the acute episode
yet does virtually nothing to prevent future episodes and demyelination.
Administration of immune-modulating beta interferon as well as
azathioprine, an immune-suppressive anti-inflammatory drug, apparently
affects the number and severity of the episodes. This is used
as long-term treatment and with episodic forms in the hope of
delaying invalidity. Cyclophosphamide, a cytostatic agent, has
proved more effective with chronic progressive forms where deterioration
is rapid.
Some frequently occurring
symptoms can be treated symptomatically such as muscle spasms
(relaxants), incontinence (bladder treatment drugs), and mobility
(physiotherapy and possibly occupational therapy).
Recommended self-help measures
include avoiding physical and mental stress as well as high temperatures
where the patient is known to be sensitive to heat. Instead regular
physical exercise is indicated in sessions which are appropriate
for the individual without causing excessive strain. Cryotherapy
sometimes brings relief. From a naturopathic viewpoint, a diet
consisting of fresh natural, mainly lacto-ovo-vegetarian foods
is recommended, avoiding coffee, tea and nicotine as well as
sugar, salt, alcohol and white flour, other than in small quantities.
The use of hippotherapy
has produced positive results.
Naturopathic methods are
used by many therapists to treat a number of MS symptoms often
with astonishing results. These include acupuncture (to relieve
symptoms and slow down the progress of the disease), homeopathy
(Agarius muscarius, Alumna, Conium, Manganum aceticum, Secale
cornutum), manual medicine (to eliminate muscular and vertebral
dysfunction, to improve microcirculation), Ordnungstherapie [lifestyle/regulative
therapy] (to overcome the problem of auto-aggression), orthomolecular
medicine (Omega 3 fatty acids, antioxidants, vitamin B, Mg),
neural therapy (to remove interference fields), physical therapy
(to restore best possible function, activation, gait training,
to learn to live independently), electrotherapy and massage (relief
from tension, relaxation, analgesics), balneotherapy and climatotherapy
(open air rest cure avoiding direct sunlight) as well as certain
environmental medical measures (cleansing and/or removal of amalgam
fillings).
How energised
inhaled air operates with multiple sclerosis
The patient puts it in
a nutshell in the introductory case study: as with the various
previous therapies, her condition was not cured by the administration
of energised inhaled air yet subjectively it had brought significant
relief to her symptoms (in contrast to all earlier therapies)
so that she was able to pursue her career fully.
What caused this subjective
improvement?
To answer this firstly
the development of the objective clinical picture of multiple
sclerosis and its accompanying subjective feelings of ill health
must be explained and secondly the mode of action of energised
inhaled air must be analysed as far as this is possible given
the current state of knowledge.
MS and accompanying subjective
feelings of ill health
Multiple sclerosis is a
disease of the nervous system. It primarily affects the white
matter of the brain and the spinal cord (pyramidal tract, posterior
white column, cranial nerves, brain stem and cerebellum) with
initially inflammation and then demyelination appearing from
a histological viewpoint. Damage in the area of the spinal cord
causes tingling, numbness, myasthenia, spasticity, paralysis
and incontinence. Damage to the white matter can provoke tiredness,
dizziness, awkward movements, myasthenia, slurred speech, blurred
vision, numbness, general weakness and trigeminal neuralgia.
Possible theories for the development of MS relate to genetic
factors, viral infections and autoimmunological processes. The
extent to which inactive molecular oxygen itself or its activated
non-radical form (singlet oxygen) as well as its toxic forms
(radicals) influence this is not clear from the current literature,
and can therefore only hypothetically be assumed to be significant.
What is quite comprehensible though is that the circulation of
the entire brain is around 50 ml/ 100g cerebral tissue and per
minute and the O2 demand is 3 ml/100g/min. Glucose serves almost
exclusively as substrate for cerebral metabolism although the
cells and their appendices consist predominantly of lipoprotein.
The metabolic and circulatory figures for the individual cerebral
structures vary considerably, depending upon their particular
functional duties and state of activity. Circulation must be
adapted to changing demand for the purposes of fully functioning
regulation. Control centres and collection points for the different
incoming and efferent pathways have a higher metabolism and are
more sensitive to injury. This also includes primarily the areas
of the midbrain, cerebellum and brain stem with large metabolically
active cells.
Airnergys mode of
action
The bodys cells all
rely on a constant supply of oxygen. This also applies especially
to the brain cells which need oxygen to produce energy to maintain
and control all the vital functions which are, without exception,
regulated by the central nervous system.
It is important to have
the right amount of oxygen at the right time and at the right
place. It is not just the absolute quantity of oxygen supplied
which is important but also its distribution and its utilisation.
The brain stem plays a particular part in this connection in
that the centres for regulating heart rate, blood pressure and
breathing as well as for the state of health, sleeping-waking
rhythm and many other vegetative functions are located here.
These are also interconnected and consequently influence one
another.
The development of energised
inhaled air was partly inspired by the discovery that oxygen
contained in the inhaled air is present in the relatively inert,
non-reactive molecular form and therefore its reactivity (exchange
process with tissue) must be increased by short-term activation.
With energised inhaled air this takes place through the production
of singlet oxygen, a stimulated but non-radicalised form. This
active state lasts only fractions of a second. The activated
oxygen reverts to its original (normal) state even before the
air is inhaled. As a result the energy previously absorbed is
released again and given off to the surrounding water through
which the inhaled air is directed.
Inhaling atmospheric oxygen
also supplies the respiratory tract with energised water due
to the inhaled air being saturated with water vapour and this
leads to the desired improved oxygen utilisation. Of the many
positive effects on the bodys systems brought about by
inhaling energised air, four stand out as important for application
with MS:
- activation of the immune
system
- improvement of circulation
- effect on protein synthesis
- stabilisation of oxidative
balance
These could all influence
the pathological process through different modes of action although
it should be stressed that other conventional methods should
not, as a result, be regarded as unimportant or even unnecessary.
Only by the interplay between recognised conventional methods
and new, not yet evidence-based, methods of therapy can complex
clinical pictures be influenced (if at all), especially if it
has not so far been possible to explain conclusively the precise
cause of their development.
A survey of end users of
energised inhaled air revealed an increase in general quality
of life in all cases with particular emphasis on energy levels
(performance, activity, resilience, motivation), state of health
(quality of sleep, mood, breathing, digestion, pain, immune state),
regeneration (deepening, acceleration, relaxation, pulse calming)
and sensory system (smell, sight, skin, giddiness). Therapists
reported improvements in functional disorders (poor performance,
sleep disorders, deficient immune defence system, poor vision)
as well as improvements in organic diseases (inflammations, disorders
of the immune system especially autoimmune diseases and allergies
as well as pain).
Even if it has not yet
been possible to demonstrate accurately the relevant links, the
descriptions ofindividual cases both from therapists and end
users make it appear likely or even very likely that these links
exist and therefore at least initial attempts should be made
to use energised inhaled air.
Descriptions of individual
cases
1. 44 year old woman; increasing
numbness from back downwards into left leg with onset of paralysis;
inflammation of central nervous system diagnosed in university
hospital; improvement following cortisone treatment; 1 year later
numbness right half of face; diagnosis: MS; injection treatment;
symptoms: insomnia, shivering, depression, anxiety, debility;
started treatment with energised inhaled air, immediate improvement,
miraculous (able to sleep, better health, more energy, resumed
work in own business)
2. M.S., wheelchair, care
level 2; since receiving treatment with energised inhaled air
no longer on cortisone, bursting with vitality, strength increased
considerably, spasticity has declined; previously only able to
read with magnifying glass (extremely blurred vision), now with
normal reading glasses; no colds now unlike before; lastly under
additional strain through acutely sick husband so totally thrown
back on own resources; unlike before now able to stand for a
few seconds without help; during a 3 week cure at a health resort
(with no treatment with energised inhaled air) no further improvement,
only after returning home and receiving inhaled air energy therapy
again was her health markedly improved, increased strength in
arms, sits more upright in wheelchair; totally new awareness
of life (first trip to the theatre since outbreak of disease);
even coped well with intense summer heat.
3. M.S. confined to a wheelchair;
since starting inhaled air energy treatment easier to breathe
deeply, gets more air; better quality of life, better health.
4. M.S., golf pro in wheelchair,
handicap 0: more restorative sleep, can concentrate for
longer; I dont feel the impairment through the MS so intensely
(since inhaled air energy therapy); energy levels much greater.
5. 40 year old woman; over
18 month period extreme tiredness, dizziness, increasingly confined
to bed, numb and tingling feeling in whole body particularly
in mouth, stiff joints and increased pressure on optic nerve;
began inhaled air energy therapy (3 x 20 mins daily!), vision
instantly improved, general state of health improved, permanent
tiredness decreased, sleeps better.
6. 31 year old man, diagnosis
by university hospital: +episodic form of M.S. with residua and
acute episodes (spontaneous double vision, unsteady gait, allergic
rhinitis); marked increase in ataxia, finger nose test dysmetric
on the right as well as sudden jerky hypometric movements especially
when looking to the left; treatment with Avonex not sufficient,
high dose cortisone and also Natalizumab recommended, prior to
this consistent results for years with inhaled air energy therapy,
above all good state of health, high activity level, able to
pursue career.